Thomas J. Schall - Dec 1, 2021 Form 4 Insider Report for ChemoCentryx, Inc. (CCXI)

Role
President and CEO, Director
Signature
/s/ Susan M. Kanaya, as Attorney-in-Fact
Stock symbol
CCXI
Transactions as of
Dec 1, 2021
Transactions value $
$499,994
Form type
4
Date filed
12/3/2021, 06:39 PM
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCXI Common Stock Options Exercise $400K +38.9K +1.69% $10.27 2.35M Dec 1, 2021 Direct
transaction CCXI Common Stock Options Exercise $100K +6.99K +0.3% $14.31 2.35M Dec 1, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCXI Stock Option (right to buy) Options Exercise -38.9K -100% 0 Dec 1, 2021 Common Stock 38.9K $10.27 Direct F1, F2
transaction CCXI Stock Option (right to buy) Options Exercise -6.99K -100% 0 Dec 1, 2021 Common Stock 6.99K $14.31 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 As of December 1, 2021, and prior to this transaction, the exercised options were fully vested.
F2 Not applicable.